• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界卫生组织药物依赖性专家委员会。第三十份报告。

WHO Expert Committee on Drug Dependence. Thirtieth report.

出版信息

World Health Organ Tech Rep Ser. 1998;873:i-vi, 1-50.

PMID:9615607
Abstract

The scale of drug dependence has grown dramatically in the past quarter-century. Preventing dependence and reducing the harm associated with the use of psychoactive substances is a challenge for health services and governments the world over. This report of a WHO Expert Committee categorizes the different types of harm that can result from psychoactive substances, whether illicit or legally available, and describes the steps that can be taken to treat health problems and stop them from occurring. The report looks at the cost and effectiveness of various treatment methods, drawing on evidence from research findings, and gives a detailed outline of the elements needed for an effective national treatment system. It addresses the question of whether dependent persons should be given a "controlled supply" of drugs and proposes for further review several substances that have potential for abuse. The Expert Committee's recommendations cover drug policies and treatment services, as well as training, information needs and research. The report lays the foundation for realistic but sound strategies in national and international efforts to reduce the health damage caused by the use of psychoactive substances.

摘要

在过去的四分之一世纪里,药物依赖的规模急剧增长。预防药物依赖并减少与使用精神活性物质相关的危害,是全球卫生服务机构和各国政府面临的一项挑战。世卫组织专家委员会的这份报告对精神活性物质(无论非法还是合法可得)可能导致的不同类型危害进行了分类,并描述了为治疗健康问题以及防止这些问题发生可采取的措施。该报告借鉴研究结果中的证据,审视了各种治疗方法的成本和效果,并详细概述了有效的国家治疗系统所需的要素。它探讨了是否应为药物依赖者提供药物“受控供应”的问题,并提议对几种有滥用潜力的物质进行进一步审查。专家委员会的建议涵盖药物政策和治疗服务,以及培训、信息需求和研究。该报告为国家和国际层面减少使用精神活性物质所造成的健康损害的切实可行且合理的战略奠定了基础。

相似文献

1
WHO Expert Committee on Drug Dependence. Thirtieth report.世界卫生组织药物依赖性专家委员会。第三十份报告。
World Health Organ Tech Rep Ser. 1998;873:i-vi, 1-50.
2
The effectiveness of drug treatment.
Res Publ Assoc Res Nerv Ment Dis. 1992;70:253-82.
3
WHO Expert Committee on Drug Dependence. Thirty-sixth report.世界卫生组织药物依赖性专家委员会。第三十六次报告。
World Health Organ Tech Rep Ser. 2015(991):1-50, back cover.
4
WHO Expert Committee on Drug Dependence.世界卫生组织药物依赖性专家委员会
World Health Organ Tech Rep Ser. 2016(998):1-34.
5
WHO expert committee on drug dependence.世界卫生组织药物依赖性专家委员会
World Health Organ Tech Rep Ser. 2012(973):1-26.
6
Provisions for Health Sector Response to Substance Use Disorders in the Indian Policy: A Critique of the National Policy on Narcotic Drugs and Psychotropic Substances.印度政策中对物质使用障碍的卫生部门应对措施的规定:对《国家麻醉药品和精神药物政策》的批判。
J Psychoactive Drugs. 2020 Jan-Mar;52(1):93-100. doi: 10.1080/02791072.2019.1709000. Epub 2020 Jan 2.
7
WHO Expert Committee on Drug Dependence.世界卫生组织药物依赖性专家委员会
World Health Organ Tech Rep Ser. 2003;915:i-v, 1-26, back cover.
8
Organizational and client determinants of cost in outpatient substance abuse treatment.门诊药物滥用治疗中成本的组织和客户决定因素。
J Ment Health Policy Econ. 2007 Mar;10(1):3-13.
9
[Methadone in the United States. The states and risk reduction].[美国的美沙酮。各州与风险降低]
Soins. 1997 Jan-Feb(612):19-22.
10
WHO Expert Committee on Drug Dependence. Thirty-second report.世界卫生组织药物依赖性专家委员会。第三十二次报告。
World Health Organ Tech Rep Ser. 2001;903:i-v, 1-26.